SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Christine Thoens, Christoph Berger, Martin Trippler, Holger Siemann, Melanie Lutterbeck, Ruth Broering, Jörg Schlaak, Falko M. Heinemann, Andreas Heinold, Jacob Nattermann, Norbert Scherbaum, Galit Alter, Joerg Timm, KIR2DL3+NKG2A− natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs, Journal of Hepatology, 2014, 61, 3, 475

    CrossRef

  2. 2
    Juan-Ramón Larrubia, Megha-Uttam Lokhande, Elia Moreno-Cubero, Silvia García-Garzón, Joaquín Miquel, Trinidad Parra-Cid, Alejandro González-Praetorious, Cristian Perna, Alicia Lázaro, Eduardo Sanz-de-Villalobos, HCV-specific CD8+ cell detection at week 12 of chronic hepatitis C treatment with PEG-interferon-α2b/ribavirin correlates with infection resolution, Cellular Immunology, 2013, 286, 1-2, 31

    CrossRef

  3. 3
    Christophe Huret, Delphine Desjardins, Mathilde Miyalou, Béatrice Levacher, Martin Amadoudji Zin, Olivia Bonduelle, Béhazine Combadière, Charlotte Dalba, David Klatzmann, Bertrand Bellier, Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice, Vaccine, 2013, 31, 11, 1540

    CrossRef

  4. 4
    Guangxu Ren, Stefan Esser, Christoph Jochum, Joerg F. Schlaak, Guido Gerken, Dirk Schadendorf, Ulf Dittmer, Gang Wu, Zhenghong Yuan, Joerg Timm, Interleukin 21 augments the hepatitis B virus-specific CD8+ T-cell response in vitro in patients coinfected with HIV-1, AIDS, 2012, 26, 17, 2145

    CrossRef

  5. 5
    G. Ahlen, A. Chen, B. Roe, T. Falkeborn, L. Frelin, W. W. Hall, M. Sallberg, J. Soderholm, Limited effect on NS3-NS4A protein cleavage after alanine substitutions within the immunodominant HLA-A2-restricted epitope of the hepatitis C virus genotype 3a non-structural 3/4A protease, Journal of General Virology, 2012, 93, Pt_8, 1680

    CrossRef

  6. 6
    Marianne Ruhl, Torben Knuschke, Kevin Schewior, Lejla Glavinic, Christoph Neumann-Haefelin, Dae-In Chang, Marina Klein, Falko M. Heinemann, Hannelore Tenckhoff, Manfred Wiese, Peter A. Horn, Sergei Viazov, Ulrich Spengler, Michael Roggendorf, Norbert Scherbaum, Jacob Nattermann, Daniel Hoffmann, Jörg Timm, CD8+ T-Cell Response Promotes Evolution of Hepatitis C Virus Nonstructural Proteins, Gastroenterology, 2011, 140, 7, 2064

    CrossRef

  7. 7
    Julia Schmidt, Robert Thimme, Christoph Neumann-Haefelin, Host genetics in immune-mediated hepatitis C virus clearance, Biomarkers in Medicine, 2011, 5, 2, 155

    CrossRef

  8. 8
    Sergei Viazov, Stefan S. Ross, Karen K. Kyuregyan, Joerg Timm, Christoph Neumann-Haefelin, Olga V. Isaeva, Oksana E. Popova, Petr N. Dmitriev, Fathia El Sharkawi, Robert Thimme, Michail I. Michailov, Michael Roggendorf, Hepatitis C virus recombinants are rare even among intravenous drug users, Journal of Medical Virology, 2010, 82, 2
  9. 9
    Christoph Neumann-Haefelin, Jörg Timm, Julia Schmidt, Nadine Kersting, Karen Fitzmaurice, Cesar Oniangue-Ndza, Michael N. Kemper, Isla Humphreys, Susan McKiernan, Dermot Kelleher, Volker Lohmann, Paul Bowness, Daniela Huzly, Hugo R. Rosen, Arthur Y. Kim, Georg M. Lauer, Todd M. Allen, Eleanor Barnes, Michael Roggendorf, Hubert E. Blum, Robert Thimme, Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope, Hepatology, 2010, 51, 1
  10. 10
    Shadi Salloum, Silvia F. Kluge, Arthur Y. Kim, Michael Roggendorf, Joerg Timm, The resistance mutation R155K in the NS3/4A protease of hepatitis C virus also leads the virus to escape from HLA-A*68-restricted CD8 T cells, Antiviral Research, 2010, 87, 2, 272

    CrossRef